Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Clinical trial NCT06932861 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06932861
- Sponsor
- Xinxin Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.